WASHINGTON (AP) — The Food and Drug Administration says its ongoing safety review of the nation's main abortion pill will continue into next year, a timeline that was quickly condemned by abortion opponents hoping to see the drug's use curtailed. The FDA gave a court-ordered update on its progress in a legal filing late Wednesday, [...]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | An appeals court is considering a push to restrict most common abortion method | 0 | 5.41 | 09-09-2026 |
| 2 | Supreme Court Reinstates Access to Abortion Pills—For Now | 0 | 7 | 04-05-2026 |
| 3 | The Supreme Court Just Hit Pause on an Abortion Pill Showdown | 0 | 7 | 15-05-2026 |
| 4 | South Korea set to approve abortion pills for the 1st time next year | 0 | 5.13 | 17-09-2026 |
| 5 | Abortion pill survivors urge Trump admin to stop defending Biden FDA policy | -8 | 4 | 09-07-2026 |
| 6 | They Came for Mifepristone. The Abortion Rights Movement Is Ready. | -2 | 7 | 07-05-2026 |
| 7 | FDA orders Eli Lilly and Novo Nordisk to remove suicide warnings from Wegovy and Zepbound | 0 | 7.76 | 15-01-2026 |
| 8 | Медицинский регулятор США сократил срок для ревакцинации препаратом Moderna | 0 | 0 | 07-01-2022 |
| 9 | FDA finds 'significant violations' committed by major manufacturer of pain relievers, ADHD drugs and anxiety medications | 0 | 6.57 | 28-04-2026 |
| 10 | Key takeaways from updated thyroid disease in pregnancy guideline | 0 | 8.75 | 16-10-2026 |